Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma

Published:2017-09-21 Issue:60 Volume:8 Page:101520-101534
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Barbhuiya Mustafa A.¹,Mirando Adam C.²,Simons Brian W.³,Lemtiri-Chlieh Ghali¹,Green Jordan J.²,Popel Aleksander S.²,Pandey Niranjan B.²,Tran Phuoc T.¹³

Affiliation:

1. Department of Radiation Oncology and Molecular and Radiation Sciences, Sidney Kimmel Comprehensive Cancer Centre, Johns Hopkins School of Medicine, Baltimore, MD, USA

2. Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Centre and Department of Urology, The Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant canstatin inhibits the progression of hepatocellular carcinoma by repressing the HIF-1α/VEGF signaling pathway;Biomedicine & Pharmacotherapy;2024-10

2. Gel-forming therapeutic peptide exhibits sustained delivery and efficacy in a mouse model of triple-negative breast cancer;Peptides;2023-11

3. Xiaoaiping injection affects the invasion and metastasis of hepatocellular carcinoma by controlling AFP expression;Oncology and Translational Medicine;2023-02

4. Deciphering signal transduction networks in the liver by mechanistic mathematical modelling;Biochemical Journal;2022-06-24

5. Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression;Frontiers in Pharmacology;2020-04-08